Irinotecan Hydrochloride Injection
Product Images NDC 72485-212

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloride (NDC 72485-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Fig3)

This text seems to be a part of a medical study or report. It provides information related to the comparison of the effectiveness of second-line Irinotecan and Best Supportive Care (BSC) in terms of patient survival. It also mentions the number of participants in the study, the duration of follow-up, and the median time of survival for each group. However, without further context or details, it is difficult to provide a more specific description or conclusion.*

FDA Label Image

Image Description (Fig4)

FDA Label Image

Image Description (Label)

This appears to be a product label for Irinotecan Hydrochloride, an injectable chemotherapy medication. The label contains information on dosing, storage, and manufacturer details.*

FDA Label Image

Image Description (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.